Research ArticleClinical Studies
Open Access

Oncological Outcomes in Men With Favorable Intermediate Risk Prostate Cancer Enrolled in Active Surveillance

PIETRO PEPE, LUDOVICA PEPE, MICHELE PENNISI and FILIPPO FRAGGETTA
In Vivo May 2024, 38 (3) 1300-1305; DOI: https://doi.org/10.21873/invivo.13569

Article Information

vol. 38 no. 3 1300-1305
DOI 
https://doi.org/10.21873/invivo.13569
PMID 
38688647
Published By 
International Institute of Anticancer Research
Print ISSN 
0258-851X
Online ISSN 
1791-7549
History 
  • Received December 28, 2023
  • Revision received January 27, 2024
  • Accepted January 29, 2024
  • Published online April 30, 2024.
Copyright & License 
Copyright © 2024 The Author(s). Published by the International Institute of Anticancer Research. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).

Author Information

  1. PIETRO PEPE1⇑,
  2. LUDOVICA PEPE1,
  3. MICHELE PENNISI1 and
  4. FILIPPO FRAGGETTA2
  1. 1Urology Unit, Cannizzaro Hospital, Catania, Italy;
  2. 2Pathology Unit, Gravina and S. Pietro Hospital, Caltagirone, Italy
  1. Correspondence to: Pietro Pepe, MD, Urology Unit, Cannizzaro Hospital, via Messina 829, Catania, Italy. Tel: +39 957263285, Fax: +39 957263259, e-mail: piepepe{at}hotmail.com
View Full Text

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Oncological Outcomes in Men With Favorable Intermediate Risk Prostate Cancer Enrolled in Active Surveillance
PIETRO PEPE, LUDOVICA PEPE, MICHELE PENNISI, FILIPPO FRAGGETTA
In Vivo May 2024, 38 (3) 1300-1305; DOI: 10.21873/invivo.13569
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords